Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Nabriva Therapeutics plc (NASDAQ: NBRV).

Full DD Report for NBRV

You must become a subscriber to view this report.


Recent News from (NASDAQ: NBRV)

Nabriva Therapeutics beats by $0.04, misses on revenue
Nabriva Therapeutics (NASDAQ: NBRV ): Q2 EPS of -$0.44 beats by $0.04 . More news on: Nabriva Therapeutics, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: August, 09 2018 07:18
Nabriva Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights
- Company preparing for potential commercialization of two first-in-class antibiotics, Lefamulin (IV and Oral) and CONTEPO (IV) in the United States in 2019 - - New Drug Application submissions expected in Q4 2018 - DUBLIN, Ireland, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Nabriva Thera...
Source: GlobeNewswire
Date: August, 09 2018 07:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-181.791.661.801.59608,345
2018-12-171.951.771.96251.7401602,829
2018-12-141.931.961.971.93119,979
2018-12-132.011.952.091.91405,399
2018-12-122.092.032.112.02229,241

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1899,127323,42030.6496Cover
2018-12-1780,488229,55635.0625Short
2018-12-1417,70146,99237.6681Short
2018-12-1376,577140,65454.4435Short
2018-12-1228,27484,14033.6035Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on NBRV.


About Nabriva Therapeutics plc (NASDAQ: NBRV)

Logo for Nabriva Therapeutics plc (NASDAQ: NBRV)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: NBRV)

      Amendment to a previously filed 8-K
      Filing Type: 8-K/AFiling Source: edgar
      Filing Date: September, 10 2018
      Preliminary proxy statement providing notification matters to be brought to a vote
      Filing Type: PRE 14AFiling Source: edgar
      Filing Date: September, 10 2018
      Amendment to the SC 13G filing
      Filing Type: SC 13G/AFiling Source: edgar
      Filing Date: August, 10 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: August, 09 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: August, 09 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: August, 07 2018
      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: August, 07 2018
      Amendment to the SC 13G filing
      Filing Type: SC 13G/AFiling Source: edgar
      Filing Date: August, 06 2018
      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: August, 03 2018
      Filing Type: CT ORDERFiling Source: edgar
      Filing Date: August, 03 2018

       

       


      Daily Technical Chart for (NASDAQ: NBRV)

      Daily Technical Chart for (NASDAQ: NBRV)


      Stay tuned for daily updates and more on (NASDAQ: NBRV)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: NBRV)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in NBRV is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of NBRV and does not buy, sell, or trade any shares of NBRV. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/